FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

CGMP Violations at Patco Cosmetics

FDA warns Indias Patco Cosmetics about CGMP violations in its manufacturing of finished over-the-counter drugs.

latest-news-card-1
Human Drugs

Dont Use Counterfeit Ozempic: FDA

FDA says it has seized thousands of units of counterfeit Ozempic that also contain counterfeit needles.

latest-news-card-1
Human Drugs

Califf Discusses More Clinical Research Options

FDA commissioner Robert Califf says a new final rule allowing some waivers of informed consent will enable minimal-risk research that would not otherw...

latest-news-card-1
Human Drugs

Topical Ophthalmic Quality Guidance

FDA publishes a draft guidance revising a recent draft on quality considerations for topical ophthalmic drugs.

latest-news-card-1
Human Drugs

CGMP Violations in Omeza Inspection

FDA warns Sarasota, FL-based Omeza about CGMP violations in its production of unapproved and misbranded over-the-counter drugs.

latest-news-card-1
Human Drugs

2nd CRL for Mercks Gefapixant Chronic Cough Drug

FDA issues a complete response letter for the Merck resubmitted NDA for gefapixant, saying the drug did not establish substantial evidence of efficacy...

latest-news-card-1
Medical Devices

Medline Recalls Trach Care and Cleaning Trays

Medline Industries recalls some lots of tracheostomy care and cleaning trays following complaints.

latest-news-card-1
Human Drugs

Insight Recalls 1 Lot of Americaine Topical Spray

FDA says Insight Pharmaceuticals is recalling one lot of its Americaine benzocaine topical anesthetic spray due to the presence of benzene from the ca...

latest-news-card-1
Human Drugs

Hua Da Trading Selling Unapproved Viagra: FDA

FDA warns Brooklyn, NY-based Hua Da Trading that it is illegally marketing a misbranded unapproved drug containing the active ingredient in Viagra as ...

latest-news-card-1
Human Drugs

Hospira Recalls 1 Bleomycin Lot

FDA says Hospira has recalled one lot of bleomycin for injection following a confirmed report of glass particulate in one vial.